Hints and tips:
Related Special Reports
...Rival biotech group Intellia Therapeutics plans to seek US approval for its own trial in the second half of 2020....
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
...According to Ben Shepherd, director of therapeutics at Organovo, the challenges ahead are about increasing the size of the tissue that can be grown....
International Edition